Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 541304 | NSE Symbol : INDOUS | ISIN : INE250Z01010 | Industry : Miscellaneous |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
17-May-2025	26-May-2025	Accounts	Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 inter alia to consider and approve Audited Financial Results for the quarter and year ended on 31-03-2025. Consider and Approve Audited Financial Results for the year ended on 31st March, 2025 (As per BSE Announcement Dated on 26/05/2025)
03-Feb-2025	11-Feb-2025	Quarterly Results	Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2025 inter alia to consider and approve Unaudited financial Results for the quarter ended on 31-12-2024. Financial Results (As Per BSE Announcement Dated on: 11/02/2025)
13-Nov-2024	21-Nov-2024	Interim Dividend	Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/11/2024 inter alia to consider and approve Declaration of Interim Dividend for the financial year 2024-25 Further the Company has fixed the Record Date' of Tuesday 26th November 2024 for the purpose of payment of Interim Dividend on Equity Shares for the Financial Year 2024- 25 if declared by the Board. This is for your kind information and dissemination. The Board Meeting to be held on 16/11/2024 has been revised to 21/11/2024 The Board Meeting to be held on 16/11/2024 has been revised to 21/11/2024. 1) We hereby intimate the Stock Exchanges as per the provisions of Regulation 29 of the SEBI(LODR) Regulations, 2015, that a meeting of the Board of Directors of M/s. Indo Us Bio Tech Limited is scheduled on Thursday, 21st November, 2024, inter alia, to consider: (a) Declaration of Interim Dividend for the financial year 2024-25 2) Further, the Company has fixed the 'Record Date' of Wednesday, 27th November, 2024 for the purpose of payment of Interim Dividend on Equity Shares for the Financial Year 2024- 25, if declared by the Board Further to our intimation dated 13th November, 2024 and in terms of Regulation 30 and Regulation 42 of the SEBI (LODR) Regulations, 2015 we wish to inform that, the Board of Directors of the Company at their meeting held today i.e. 21st November, 2024 has inter-alia; Declared an interim dividend of Rs. 0.25 per equity share of Rs. 10 each fully paid-up for the financial year 2024-25. As informed on 13th November, 2024, the Company has fixed Tuesday, 3rd December, 2024 as 'Record Date' for the purpose of payment of Interim Dividend on equity shares for the Financial Year 2024-25 and the payment of Interim Dividend will be completed on or before 19th December, 2024. The meeting of the Board of Directors commenced at 11:20 AM to 11:40 AM. This is for your kind information and dissemination. (As Per BSE Announcement dated on 21.11.2024)
06-Nov-2024	14-Nov-2024	Quarterly Results	Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve and take on record the Un-Audited Standalone Financial Result of the Company for the quarter and half year ended 30th September 2024 and to consider any other matter with the permission of the Board. Please take the same on your record. Thanking You Outcome of Board Meeting (As Per BSE Announcement Dated on 14.11.2024)
06-Sep-2024	06-Sep-2024	AGM	Outcome of Board Meeting
01-Aug-2024	08-Aug-2024	Quarterly Results	Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2024 ,inter alia, to consider and approve the Unaudited Standalone Financial Result of the Company for the quarter ended 30th June, 2024. Please take the same on your record. Thanking You, Pursuant to the Regulation 30 of the SEBI (Listing Obligation and Disclosures Requirements) Regulation, 2015, we wish to inform you that the Board of Directors of the Company at their meeting held on Thursday, 8th August 2024 at the registered office of the Company situated at 309, Shanti Mall, Satadhar Char Rasta, Opp. Navrang Tower, Sola Road, Ahmedabad, Gujarat, 380061 have considered and approved the following items of business: 1. The Board approved unaudited financial results of the company for the quarter ended 30th June, 2024 along with limited review reports obtained from the Auditor of the Company. The Board Meeting commenced at 11.00 A.M. and concluded at 11:40 A.M. You are requested to kindly take the same on record. Thanking you, Read less.. Financial Results for the quarter ended on 30th June, 2024. (As Per BSE Announcement Dated on 08.08.2024)
17-May-2024	14-May-2024	Quarterly Results	We are submitting the Revised Financial Results; The statement of Standalone Audited Financial Results of the Company for the period of March 31, 2024.
25-Apr-2024	02-May-2024	Quarterly Results	Quarterly Results & Audited Results With reference to above, we hereby inform that meeting of Board of Directors of the Company held today (i.e., 02/05/2024), in which Board has approved and adopted the standalone Audited Financial Results of the Company for the Quarter and year ended 31st March, 2024. Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose the following: 1. Standalone Audited Financial Results of the Company for quarter and year ended on 31st March, 2024. 2. Auditors'' Report on Standalone Audited Financial Results. These are also being made available on the website of the Company at www.indousagriseeds.com Audited Financial Results for the year ended on 31st March, 2024. (As per BSE Announcement Dated on 02/05/2024)
06-Feb-2024	14-Feb-2024	Quarterly Results	Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve the Un-Audited Financial results of the Company along with the Limited Review reports for the Quarter and Nine Months ended December 31 2023 and Any Other Business with the Permission of the Chair. You are requested to take the same on records. Thanking You
24-Jan-2024	24-Jan-2024	Change in Directors	Re-appointment of Ms. Priyanka Jagdishbhai Ajudia (DIN: 07941023) as an Executive Director of the Company for a further period of five (5) years , Re-appointment of Mrs. Ritaben Nileshbhai Kikani (DIN: 08367656) as an Independent Director of the Company for a second term of five (5) years , Approved Notice of Postal Ballot, The Board meeting commenced at 17:00 pm and concluded at 17:30 pm. Request you to please take the above information on records. Thanking you,
01-Nov-2023	08-Nov-2023	Quarterly Results	Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve the Un-Audited Standalone Financial Result of the Company for the quarter and half year ended 30th September 2023 and to consider any other matter with the permission of the Board. Please take the same on your record. Thanking You Dear Sir, Pursuant to the Regulation 30 of the SEBI (Listing Obligation and Disclosures Requirements) Regulation, 2015, we wish to inform you that the Board of Directors of the Company at their meeting held on Wednesday, 8th November, 2023 at the registered office of the Company situated at 309, Shanti Mall, Satadhar Char Rasta, Opp. Navrang Tower, Sola Road, Ahmedabad, Gujarat, 380061 have considered and approved the following items of business: 1. The Board approved unaudited financial results of the company for the quarter/half year ended 30th September, 2023 along with limited review reports obtained from the Auditor of the Company. The Board Meeting commenced at 05.30 P.M. and concluded at 06:00 P.M. You are requested to kindly take the same on record. Thanking you, Unaudited Financial Results for the quarter and half year ended on 30-09-2023. (As per BSE Announcement Dated on 08/11/2023)
07-Sep-2023	07-Sep-2023	AGM	Outcome of Board Meeting
01-Sep-2023	01-Sep-2023	Bonus Issue	This is to inform you that, the Board of Directors at their Meeting held on today i.e., 1st September, 2023 at 10:00 AM. at the registered office of the Company, has allotted 10026000 (one crore twenty six thousand) bonus equity shares of face Value Rs. 10/- (Rupees Ten Only) each, to the equity shareholder entitled thereto as on 29th August, 2023, being the Record Date fixed for the purpose. The Board Meeting started at 10:00 A.M. and ended on 10:30 A.M. Kindly acknowledge the receipt and update your website with the same. Thanking you
05-Aug-2023	12-Aug-2023	Quarterly Results	Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2023 inter alia to consider and approve the Unaudited Standalone Financial Result of the Company for the quarter ended 30th June 2023. Further in continuation of our letter dated 30th June 2023 and in terms of the Indo Us Bio Tech Limited the trading window for insiders which is already closed with effect from 1st July 2023 shall continue to remain closed till 48 (Forty Eight) hours after the dissemination of the un-audited Standalone financial results of the Company (both days inclusive) for quarter ended 30thJune 2023. Please take the same on your record. Thanking You Dear Sir, Pursuant to the Regulation 30 of the SEBI (Listing Obligation and Disclosures Requirements) Regulation, 2015, we wish to inform you that the Board of Directors of the Company at their meeting held on Saturday, 12th August 2023 at the registered office of the Company situated at 309, Shanti Mall, Satadhar Char Rasta, Opp. Navrang Tower, Sola Road, Ahmedabad, Gujarat, 380061 have considered and approved the following items of business: 1. The Board approved unaudited financial results of the company for the quarter ended 30th June, 2023 along with limited review reports obtained from the Auditor of the Company. The Board Meeting commenced at 05.30 P.M. and concluded at 06:30 P.M. You are requested to kindly take the same on record. Thanking you, (As per BSE Announcement Dated on 12/08/2023)
30-Jun-2023	07-Jul-2023	Bonus Issue	Indo Us Bio-Tech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/07/2023 inter alia to consider and approve (1) To increase Authorised Share Capital of the Company. (2) To recommend for the Issue of Bonus Shares to the existing Shareholders of the company. (3) To Call the Extra Ordinary General Meeting for the purpose of approval of above agendas. (4) Any other Matter with the permission of the Chair. Please take the same on your record and oblige. Thanking you. Board approved:- I. Increase in Authorised Share Capital of the Company from Rs. 11,00,00,000 (Eleven Crores only), divided into 1,10,00,000 Equity Shares of Re. 10/- (Rupee Ten Only) each to Rs. 21.00,00,000 (Twenty onc Crores only), divided into 2,10,00,000 Equity Shares of Re. 10/- (Rupee Ten Only) each and consequent change in Capital Clause of Memorandum of Association of the Company. 2. The Board recommended the Bonus Issue of Equity Shares in the proportion of 1 (One) Equity Share of Rs, 10/- each for every 1 (one) Equity Shares of Re 10/- each held by the shareholders of the Company as on the record date. 3. Considered and approved Notice of Postal Ballot subject to the approval of the shareholders of the Company and applicable regulatory authorities. 4.The appointment of CS Amrish Gandhi (Membership No. F8193), Proprietor of M/S Amrish Gandhi & Associates as a matters. Scrutinizer for conducting Postal Ballot and E-Voting Process in fair and transparent manner for the above subject (As Per BSE Bulletin Dated on 07.07.2023) Outcome of Board Meeting (As Per BSE Announcement Dated on 07.07.2023)

1 2 3

LOGIN HERE

Indo US Bio-Tech Ltd

Board Meeting